会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 45. 发明授权
    • Cytochrome P450 oxygenases
    • 细胞色素P450加氧酶
    • US08076114B2
    • 2011-12-13
    • US12754216
    • 2010-04-05
    • Edgardo T FarinasFrances H. ArnoldUlrich SchwanebergAnton Glieder
    • Edgardo T FarinasFrances H. ArnoldUlrich SchwanebergAnton Glieder
    • C12N9/02C12N15/00C12N1/20C12P21/04C07H21/04C12Q1/26
    • C12N9/0071C12P7/02C12P7/04C12P7/16C12P17/02Y02E50/10Y02P20/52
    • Nucleic acids encoding cytochrome P450 variants are provided. The cytochrome P450 variants of have a higher alkane-oxidation capability, alkene-oxidation capability, and/or a higher organic-solvent resistance than the corresponding wild-type or parent cytochrome P450 enzyme. A preferred wild-type cytochrome P450 is cytochrome P450 BM-3. Preferred cytochrome P450 variants include those having an improved capability to hydroxylate alkanes and epoxidate alkenes comprising less than 8 carbons, and have amino acid substitutions corresponding to V78A, H236Q, and E252G of cytochrome P450 BM-3. Preferred cytochrome P450 variants also include those having an improved hydroxylation activity in solutions comprising co-solvents such as DMSO and THF, and have amino acid substitutions corresponding to T235A, R471A, E494K, and S1024E of cytochrome P450 BM-3.
    • 提供了编码细胞色素P450变体的核酸。 细胞色素P450变体具有比相应的野生型或亲本细胞色素P450酶更高的烷烃氧化能力,烯烃氧化能力和/或较高的有机溶剂耐受性。 优选的野生型细胞色素P450是细胞色素P450 BM-3。 优选的细胞色素P450变体包括具有改善含有少于8个碳原子的烷烃和环氧化烯烃羟基化能力以及对应于细胞色素P450 BM-3的V78A,H236Q和E252G的氨基酸取代的那些变体。 优选的细胞色素P450变体还包括在包含共溶剂如DMSO和THF的溶液中具有改善的羟基化活性的那些,并且具有对应于细胞色素P450 BM-3的T235A,R471A,E494K和S1024E的氨基酸取代。
    • 46. 发明申请
    • CYTOCHROME P450 OXYGENASES
    • CYTOCHROME P450氧化剂
    • US20100248327A1
    • 2010-09-30
    • US12754216
    • 2010-04-05
    • Edgardo T. FarinasFrances H. ArnoldUlrich SchwanebergAnton Glieder
    • Edgardo T. FarinasFrances H. ArnoldUlrich SchwanebergAnton Glieder
    • C12N9/02C07H21/04
    • C12N9/0071C12P7/02C12P7/04C12P7/16C12P17/02Y02E50/10Y02P20/52
    • Nucleic acids encoding cytochrome P450 variants are provided. The cytochrome P450 variants of have a higher alkane-oxidation capability, alkene-oxidation capability, and/or a higher organic-solvent resistance than the corresponding wild-type or parent cytochrome P450 enzyme. A preferred wild-type cytochrome P450 is cytochrome P450 BM-3. Preferred cytochrome P450 variants include those having an improved capability to hydroxylate alkanes and epoxidate alkenes comprising less than 8 carbons, and have amino acid substitutions corresponding to V78A, H236Q, and E252G of cytochrome P450 BM-3. Preferred cytochrome P450 variants also include those having an improved hydroxylation activity in solutions comprising co-solvents such as DMSO and THF, and have amino acid substitutions corresponding to T235A, R471A, E494K, and S1024E of cytochrome P450 BM-3.
    • 提供了编码细胞色素P450变体的核酸。 细胞色素P450变体具有比相应的野生型或亲本细胞色素P450酶更高的烷烃氧化能力,烯烃氧化能力和/或较高的有机溶剂耐受性。 优选的野生型细胞色素P450是细胞色素P450 BM-3。 优选的细胞色素P450变体包括具有改善含有少于8个碳原子的烷烃和环氧化烯烃羟基化能力以及对应于细胞色素P450 BM-3的V78A,H236Q和E252G的氨基酸取代的那些变体。 优选的细胞色素P450变体还包括在包含共溶剂如DMSO和THF的溶液中具有改善的羟基化活性的那些,并且具有对应于细胞色素P450 BM-3的T235A,R471A,E494K和S1024E的氨基酸取代。
    • 49. 发明申请
    • Cytochrom P450 oxygenases
    • 细胞色素P450加氧酶
    • US20080293928A1
    • 2008-11-27
    • US11800970
    • 2007-05-07
    • Edgardo T. FarinasFrances H. ArnoldUlrich SchwanebergAnton Glieder
    • Edgardo T. FarinasFrances H. ArnoldUlrich SchwanebergAnton Glieder
    • C07H21/04
    • C12N9/0071C12P7/02C12P7/04C12P7/16C12P17/02Y02E50/10Y02P20/52
    • Nucleic acids encoding cytochrome P450 variants are provided. The cytochrome P450 variants of have a higher alkane-oxidation capability, alkene-oxidation capability, and/or a higher organic-solvent resistance than the corresponding wild-type or parent cytochrome P450 enzyme. A preferred wild-type cytochrome P450 is cytochrome P450 BM-3. Preferred cytochrome P450 variants include those having an improved capability to hydroxylate alkanes and epoxidate alkenes comprising less than 8 carbons, and have amino acid substitutions corresponding to V78A, H236Q, and E252G of cytochrome P450 BM-3. Preferred cytochrome P450 variants also include those having an improved hydroxylation activity in solutions comprising co-solvents such as DMSO and THF, and have amino acid substitutions corresponding to T235A, R471A, E494K, and S1024E of cytochrome P450 BM-3.
    • 提供了编码细胞色素P450变体的核酸。 细胞色素P450变体具有比相应的野生型或亲本细胞色素P450酶更高的烷烃氧化能力,烯烃氧化能力和/或较高的有机溶剂耐受性。 优选的野生型细胞色素P450是细胞色素P450 BM-3。 优选的细胞色素P450变体包括具有改善含有少于8个碳原子的烷烃和环氧化烯烃羟基化能力以及对应于细胞色素P450 BM-3的V78A,H236Q和E252G的氨基酸取代的那些变体。 优选的细胞色素P450变体还包括在包含共溶剂如DMSO和THF的溶液中具有改善的羟基化活性的那些,并且具有对应于细胞色素P450 BM-3的T235A,R471A,E494K和S1024E的氨基酸取代。